Pages that link to "Q38721255"
Jump to navigation
Jump to search
The following pages link to PDE5 inhibitors enhance the lethality of [pemetrexed sorafenib]. (Q38721255):
Displaying 5 items.
- [pemetrexed sildenafil], via autophagy-dependent HDAC down-regulation, enhances the immunotherapy response of NSCLC cells (Q38622540) (← links)
- Synergistic activity of sorafenib and betulinic acid against clonogenic activity of non-small cell lung cancer cells. (Q43298298) (← links)
- HDAC inhibitors enhance neratinib activity and when combined enhance the actions of an anti-PD-1 immunomodulatory antibody in vivo (Q45073629) (← links)
- Repurposing drugs in oncology (ReDO)-selective PDE5 inhibitors as anti-cancer agents. (Q55247585) (← links)
- The progression of HMGB1-induced autophagy in cancer biology (Q60924219) (← links)